Femme et Homme
- | Pays :
- Switzerland
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to assess the antitumor activity (in terms of overall response rate - ORR - i.e. sum of complete and partial responses)of bortezomib in pretreated MALT lymphomas with one prior sistemic therapy regimen
Critère d'inclusion
- Lymphoma, Mucosa-Associated Lymphoid Tissue